WEBULL
WebtradeDownload

Keurig Dr Pepper (KDP) After Strong Q3 And Alta Launch Looks Near Fair Value

Simply Wall St · 2d ago

Keurig Dr Pepper (KDP) moved back into focus after reporting third quarter results that showed higher sales and profit, along with reaffirmed full year guidance and the high profile launch of its Keurig Alta System.

That backdrop helps explain why Keurig Dr Pepper’s share price has picked up momentum, with a 30 day share price return of 15.33% and a 90 day gain of 25.02%, while the 1 year total shareholder return of 45.60% points to a longer run of improving sentiment as the Alta launch and recent earnings land in the market’s sights.

Spot emerging consumer brands showing similar momentum to Keurig Dr Pepper by scanning our hand picked 38 high quality undervalued stocks that pair cash generation with balance sheet strength.

After a jump like that, some investors will feel pressure to act fast on Keurig Dr Pepper, while others prefer to wait for a calmer entry. Does the current valuation already bake in this surge in enthusiasm?

Most Popular Narrative: 90% Undervalued

Keurig Dr Pepper’s most followed narrative pegs fair value at $36.97, which sits slightly above the recent $36.63 close. It also connects that view to how the business manages its beverage strength, coffee pressures and the planned 2027 split.

The combination of reaffirmed 2026 guidance for US$25.9b to US$26.4b in net sales, low double digit constant currency EPS growth and progress toward about 4.1x management leverage by year end, supported by about US$2.5b targeted free cash flow and asset monetizations, could improve cash generation available for debt reduction and shareholder returns.

See why 35 investors see Keurig Dr Pepper as 1% undervalued.

Result: Fair Value of $36.97 (UNDERVALUED)

Still, the Keurig Dr Pepper story could change quickly if coffee segment weakness persists or if the planned split and JDE Peet’s integration hit execution snags.

Find out about the key risks to this Keurig Dr Pepper narrative.

Another View on Keurig Dr Pepper’s Valuation

The earlier fair value narrative leans on analyst targets and earnings forecasts. A simple P/E check paints a tougher picture. Keurig Dr Pepper trades around 33x earnings, compared with about 25.3x for peers and a fair ratio of 25.7x, which points to richer pricing and less margin for error.

That kind of premium can work if the story keeps improving. It also raises the stakes if coffee pressure and the 2027 split do not play out cleanly enough for investors.

See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:KDP P/E Ratio as at Nov 2026
NasdaqGS:KDP P/E Ratio as at Nov 2026

Next Steps

Sentiment around Keurig Dr Pepper is split between optimism and caution, so move quickly and stress test the story against both sides. To weigh the potential upsides against the watchpoints that keep investors on edge, start by reviewing the 2 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Keurig Dr Pepper?

Do not stop with Keurig Dr Pepper. Put this momentum to work by lining up a shortlist of other opportunities that match your risk profile and income goals.